Document is current
Any future updates will be listed below
-
Authors
Doe, Elom
Alabi, Abigail
Chakka, Leela Raghava Jaidev
Maniruzzaman, Mohammed https://orcid.org/0000-0002-3373-5586
- License Information
-
More Information
Article History
Received: 9 January 2026
Accepted: 23 February 2026
First Online: 6 March 2026
Declarations
:
: Dr Mo Maniruzzaman holds stock in, serves on a scientific advisory board for or is a consultant for CoM3D (Surrey, UK), DosePlus Therapeutics (Princeton, NJ, USA), Septum Solutions (Houston, TX, USA) and SmarGic Tech LLC (Oxford, MS, USA). The companies had no role in the design of the study, in the collection, analysis or interpretation of data. L.R. Jaidev Chakka holds stock in SmarGic LLC (Oxford, MS, USA).
